Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04556201 · ClinicalTrials.gov registry record · NA
The Performance of the SOLTIVE Laser System for Laser Lithotripsy in Kidney or Ureteral Stones
A NA study, sponsored by Olympus Corporation of the Americas.
- Completed
- Registry status
- NA
- Development phase
- 450
- Enrollment target
NCT04556201: Completed NA study, sponsored by Olympus Corporation of the Americas.
NCT04556201 is a NA study that has completed, run by Olympus Corporation of the Americas. The registered enrollment target is 450 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04556201, a NA study, has completed, sponsored by Olympus Corporation of the Americas.
- COMPLETED
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
Study Summary
The purpose of this study is to collect real-world evidence on the performance of the SOLTIVE™ Premium SuperPulsed Laser System for laser lithotripsy in ureteroscopy, percutaneous nephrolithotomy (PCNL) and mini PCNL for kidney and ureteral stones.
Primary Outcome
Stone free rate as determined by standard of care imaging
Interventions
- DEVICE SOLTIVE™ Premium SuperPulsed Laser Fiber System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2023-05-30 |
| Phase | NA |
What the finished NCT04556201 record still lists
NCT04556201 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 1 intervention - of which SOLTIVE™ Premium SuperPulsed Laser Fiber System is the first listed.
NCT04556201 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04556201 about?
NCT04556201 is a clinical study titled "The Performance of the SOLTIVE Laser System for Laser Lithotripsy in Kidney or Ureteral Stones". The purpose of this study is to collect real-world evidence on the performance of the SOLTIVE™ Premium SuperPulsed Laser System for laser lithotripsy in ureteroscopy, percutaneous nephrolithotomy (PCNL) and mini PCNL for kidney and ureteral stones.
What is the current status of trial NCT04556201?
This trial is currently completed. It is a NA study. The enrollment target is 450 participants. The study started on 2020-12-01. Estimated completion is 2023-05-30.
What interventions are being tested in trial NCT04556201?
The interventions under investigation include: SOLTIVE™ Premium SuperPulsed Laser Fiber System (DEVICE).
Who is sponsoring clinical trial NCT04556201?
This trial is sponsored by Olympus Corporation of the Americas, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04556201's enrollment target sits among peer trials
450 225th of 2000 higher than 1,768 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI